HUP9900438A2 - Pirazolo[4,3-d]pirimidin-7-on-származékok alkalmazása gerincvelő-sérülés következtében fellépő impotencia kezelésére használható gyógyszerkészítmények előállítására - Google Patents

Pirazolo[4,3-d]pirimidin-7-on-származékok alkalmazása gerincvelő-sérülés következtében fellépő impotencia kezelésére használható gyógyszerkészítmények előállítására

Info

Publication number
HUP9900438A2
HUP9900438A2 HU9900438A HUP9900438A HUP9900438A2 HU P9900438 A2 HUP9900438 A2 HU P9900438A2 HU 9900438 A HU9900438 A HU 9900438A HU P9900438 A HUP9900438 A HU P9900438A HU P9900438 A2 HUP9900438 A2 HU P9900438A2
Authority
HU
Hungary
Prior art keywords
spinal cord
cord injury
treaing
pyrazolo
pyrimidin
Prior art date
Application number
HU9900438A
Other languages
English (en)
Inventor
Murray Craig Maytom
Ian Howard Osterloh
Original Assignee
Pfizer Research And Development Company N.V./S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research And Development Company N.V./S.A. filed Critical Pfizer Research And Development Company N.V./S.A.
Publication of HU9900438D0 publication Critical patent/HU9900438D0/hu
Publication of HUP9900438A2 publication Critical patent/HUP9900438A2/hu
Publication of HUP9900438A3 publication Critical patent/HUP9900438A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A találmány tárgyát cGMP PDE inhibitőr vegyületeknek, többek között asidenafilnak és gyógyászatilag elfőgadható sóinak alkalmazása képezigerincvelő-sérülés következtében fellépő szexűális működési zavarőkkezelésére használható gyógyszerkészítmények előállítására. ŕ
HU9900438A 1998-02-23 1999-02-22 Use of pyrazolo[4,3-d]pyrimidin-7-one derivatives for the preparation of pharmaceutical compositions treaing sexual dysfunctions due to spinal cord injury HUP9900438A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7558098P 1998-02-23 1998-02-23

Publications (3)

Publication Number Publication Date
HU9900438D0 HU9900438D0 (en) 1999-04-28
HUP9900438A2 true HUP9900438A2 (hu) 2000-03-28
HUP9900438A3 HUP9900438A3 (en) 2002-01-28

Family

ID=22126701

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900438A HUP9900438A3 (en) 1998-02-23 1999-02-22 Use of pyrazolo[4,3-d]pyrimidin-7-one derivatives for the preparation of pharmaceutical compositions treaing sexual dysfunctions due to spinal cord injury

Country Status (17)

Country Link
US (1) US20060040935A1 (hu)
EP (1) EP0951908B1 (hu)
JP (1) JPH11315025A (hu)
KR (1) KR19990072798A (hu)
AT (1) ATE279194T1 (hu)
AU (1) AU755402B2 (hu)
CA (1) CA2262268C (hu)
DE (1) DE69921008T2 (hu)
DK (1) DK0951908T3 (hu)
ES (1) ES2226281T3 (hu)
HU (1) HUP9900438A3 (hu)
IL (1) IL128532A0 (hu)
MY (1) MY133446A (hu)
NZ (1) NZ334333A (hu)
PT (1) PT951908E (hu)
TW (1) TW542719B (hu)
ZA (1) ZA991393B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
AU4663100A (en) 1999-04-30 2000-11-17 Lilly Icos Llc Treatment of female arousal disorder
US6803365B2 (en) 1999-12-24 2004-10-12 Bayer Aktlengesellschaft Imidazo[1,3,5]triazinones and the use thereof
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
EP1404336A1 (en) * 2001-06-14 2004-04-07 Sampad Bhattacharya Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
KR100393160B1 (ko) * 2001-06-14 2003-07-31 한국과학기술연구원 신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도
NZ551356A (en) 2004-05-11 2009-09-25 Emotional Brain Bv Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
EP1925307A1 (en) 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
WO2008142396A1 (en) * 2007-05-18 2008-11-27 Anthony Denis Maher Methods of assessing male fertility using a uridine marker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
DE69921008T2 (de) 2006-02-02
TW542719B (en) 2003-07-21
HU9900438D0 (en) 1999-04-28
DE69921008D1 (de) 2004-11-18
CA2262268C (en) 2003-07-29
HUP9900438A3 (en) 2002-01-28
AU755402B2 (en) 2002-12-12
PT951908E (pt) 2005-01-31
ES2226281T3 (es) 2005-03-16
NZ334333A (en) 2000-11-24
EP0951908B1 (en) 2004-10-13
US20060040935A1 (en) 2006-02-23
EP0951908A2 (en) 1999-10-27
CA2262268A1 (en) 1999-08-23
AU1839099A (en) 1999-09-09
JPH11315025A (ja) 1999-11-16
ATE279194T1 (de) 2004-10-15
DK0951908T3 (da) 2004-12-27
KR19990072798A (ko) 1999-09-27
ZA991393B (en) 2000-08-22
MY133446A (en) 2007-11-30
IL128532A0 (en) 2000-01-31
EP0951908A3 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
HUP9900438A2 (hu) Pirazolo[4,3-d]pirimidin-7-on-származékok alkalmazása gerincvelő-sérülés következtében fellépő impotencia kezelésére használható gyógyszerkészítmények előállítására
ES2166270A1 (es) Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
EA200200337A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[4,3-d]ПИРИМИДИНА
WO2001087038A3 (en) β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
MY119181A (en) Aryl pyrimidine derivatives
CA2401229A1 (en) Aryl fused azapolycyclic compounds
TNSN06226A1 (en) Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
IL114003A (en) 1,4,6-Trisubstituted 1H-pyrrolo[2,3-b]pyridine and 1-H-pyrazolo[3,4-b] pyridine derivatives and pharmaceutical compositions containing them and some intermediates for their preparation
HU0102272D0 (en) Compositions and methods for stimulating gastrointestinal motilis
ECSP088413A (es) Preparación y uso de derivados de tetrahidropirrolo[3,2-c]piridin-4-ona para el tratamiento de la obesidad, trastornos psiquiátricos y neurológicos
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
WO2006016067A3 (fr) Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer
UA27252C2 (uk) Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
EA200000355A2 (ru) Промышленные изделия
MY122042A (en) Pro-drugs and counterparts of camptothecin, their application as medicines
HK1040905B (zh) 噠嗪並(4，5-b)吲哚-1-乙酰胺衍生物在製備用於治療與周圍神經受體苯並二氮雜䓬的失調有關的疾病的藥物中的用途
CA2342830A1 (en) 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
WO2002004457A8 (en) Azepino[4,5-b]pyrano[3,2-e]indoles
EP1634883A4 (en) PHENYL-5,7-DIALALKYL-3,7-DIHYDROPYRROL-2,3-D PYRIMIDINE-4-ONE DERIVATIVES SUBSTITUTED IN POSITION 2, THEIR PREPARATION AND THEIR USE IN PHARMACY
WO2001007418A3 (en) Ceramide analogs, process for their preparation and their use as antitumor agents
WO1999005103A3 (en) 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
WO2002000656A3 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives